Generic placeholder image

Current HIV Research


ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Research Article

Cervical Cytology and Herpes Simplex Virus Type-2 Serology Among Human Immune Deficiency Virus Infected Women on Highly Active Antiretroviral Therapy in Enugu, Nigeria

Author(s): Cornelius Osinachi Ogu*, Peter Uwadiegwu Achukwu, Peter Onubiwe Nkwo, Rita Ifeoma-Ossy Ogu, Okechukwu Steven Onwukwe, Nkiruka Chinonye Azubuike, Anulika Obianuju Onyemelukwe, Ijeoma Maryjoy Ifeorah and Maduakor Charity Uzoamaka

Volume 20, Issue 6, 2022

Published on: 21 November, 2022

Page: [463 - 471] Pages: 9

DOI: 10.2174/1570162X21666221114102411

Price: $65


Background: The prevalence of Human Immunodeficiency Virus (HIV) and Herpes Simplex Virus type-2 (HSV-2) infections are high and the programme for Cervical Cancer Screening is weak in Nigeria.

Objectives: Prevalence of Herpes Simplex Virus Type-2 co-infection and cervical cytology among HSV-2 co-infected Human Immunodeficiency Virus Sero-positive (HIV+) women on Highly Active Antiretroviral Therapy (HAART) attending Human Immunodeficiency Virus clinic at University of Nigeria Teaching Hospital (UNTH) Ituku/Ozalla Enugu, Nigeria.

Methods: A cross-sectional, hospital-based study. Active participants included 105 HIV seropositive women on HAART and104 HIV seronegative (HIV-) women who passed inclusion criteria and signed written informed consent. Each participant was coded with a specific number. A structured questionnaire was used to obtain the socio-demographic and medical history. Serum was obtained for HSV-2 serology test for all participants and HIV screening for HIV-negative participants. Cervical smears were collected for Papanicolaou stains and Immunocytochemistry using anti-P16INKa antibody.

Results: Prevalence of HSV-2+ was 50.5% among HIV+ women on HAART and 16.3% among HIV- women, Odds Ratios [95% CI]; p-value was 5.21 [2.74-9.94]; p < 0.0001. HIV+ women on HAART co-infected with HSV-2 significantly had more Cervical Lesions, 11.4% compared to HIVwomen uninfected with HSV-2, 4.8%, OR [95% CI]; p-value 4.8 (1.58-14.54); p = 0.006.

Conclusion: The prevalence of HSV-2 was significantly high among HIV+ women on HAART. HSV-2+ co-infection could be an enhancer of Cervical Lesions among HIV+ women on HAART. Hence, anti-herpetic agent introduction and screening for HSV-2 among HIV+ patients are recommended.

Keywords: Cervical cytology, herpes simplex virus type-2, co-infected, human immunodeficiency virus, SIL, HAART, antiretroviral therapy.

Graphical Abstract
National Agency for the Control of AIDS Nigeria. Nigeria prevalence rate, National HIV and AIDS strategic framework 2019. Available from: (Accessed on: 8th March 2020).
UNSAIDS. Unaidsinfo 2019. Available from: (Accessed on: 5th July 2020).
UNICEF. At a glance, Nigeria-Statistics 2010. Available from: (Accessed on: 12th July, 2018).
Media centre. cancer facts sheets 2012. Available from: (Accessed on: 10th June, 2016).
Dim CC, Nwagha UI, Ezegwui HU, Dim NR. The need to incorporate routine cervical cancer counselling and screening in the management of women at the outpatient clinics in Nigeria. J Obstet Gynaecol 2009; 29(8): 754-6.
[] [PMID: 19821672]
U.S. Preventive Services Task Force. Screening for cervical cancer control. 2012. Available from: http/ (accessed on: 3rd May, 2016).
Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101(16): 1120-30.
[] [PMID: 19648510]
Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Mortality Morbidity Weekly Report. Recommendation Report 1992; 41(RR-17): 1-19.
Looker KJ, Magaret AS, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One 2015; 10(1): e114989.
[] [PMID: 25608026]
Des Jarlais DC, Hagan H, Arasteh K, McKnight C, Perlman D, Friedman SR. Herpes simplex virus-2 and HIV among noninjecting drug users in New York city. Sex Transm Dis 2007; 34(11): 923-7.
[] [PMID: 18049425]
Hagan H, Jenness SM, Wendel T, Murrill CR, Neaigus A, Gelpi-Acosta C. Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas. Int J STD AIDS 2010; 21(8): 580-3.
[] [PMID: 20975092]
Patel P, Bush T, Mayer KH, et al. Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States. Sex Transm Dis 2012; 39(2): 154-60.
[] [PMID: 22249305]
Corey L, Langenberg AGM, Ashley R, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. JAMA 1999; 282(4): 331-40.
[] [PMID: 10432030]
Brown EL, Wald A, Hughes JP, et al. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol 2006; 164(8): 733-41.
[] [PMID: 16896053]
Barnabas RV, Wasserheit JN, Huang Y, et al. Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study). J Acquir Immune Defic Syndr 2011; 57(3): 238-44.
[] [PMID: 21860356]
Nagot N, Ouedraogo A, Konate I, et al. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immu-nodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis 2008; 198(2): 241-9.
[] [PMID: 18593294]
Sheth PM, Sunderji S, Shin LYY, et al. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis 2008; 197(10): 1394-401.
[] [PMID: 18444797]
Roxby AC, Drake AL, John-Stewart G, et al. Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women. PLoS One 2011; 6(5): e19947.
[] [PMID: 21637835]
Tan DHS, Raboud JM, Kaul R, Walmsley SL. Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: An observational cohort study. BMJ Open 2014; 4(1): e004210.
[] [PMID: 24464523]
Ojinmah UR, Nnoruka EN, Ozoh GA, Onyekonwu CL, Aguwa EN. Herpes simplex virus type 2 infection among females in Enugu, Enugu State. Niger J Med 2012; 21(4): 394-403.
[PMID: 23304946]
Anaedobe C, Ajani T. Co-infection of herpes simplex virus Type 2 and HIV infections among pregnant women in Ibadan, Nigeria. J Glob Infect Dis 2019; 11(1): 19-24.
[] [PMID: 30814831]
Drisu UI, Oronsaye FE, Adejumo BIG, et al. Seroprevalence, type-specific of herpes simplex virus and associated risk factors among women of child bearing age in kogi state, Nigeria. Health (Irvine Calif) 2018; 10(7): 1006-17.
Kalu EI. Seroprevalence of herpes simplex virus infections among pregnant women attending antenatal clinic in Benin, Nigeria. Int J Trop Dis Health 2013; 4: 70-81.
Ameli N, Bacchetti P, Morrow RA, et al. Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS 2006; 20(7): 1051-8.
[] [PMID: 16603858]
Federal Ministry of Health (Nigeria). National survey on HIV/AIDS and reproductive health survey Federal Ministry of Health, Abuja, Nigeria 2006. Available from: (Accessed on: 7th June, 2016).
Clinical Trials: A practical Approach Power calculator for binary outcome superiority trial 2012. Available from: http://www. (Accessed on: 22nd February 2017).
Chukwuali LI, Onuigbo WIB, Mgbor NC. A ten year descriptive analysis of women availing themselves of the cervical cancer screening service at medical women center, Enugu South Eastern Nigeria. Trop J Obstet Gynaecol 2003; 20(2): 109-12.
Ononogbu U, Almujtaba M, Modibbo F, et al. Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health 2013; 13(1): 582.
[] [PMID: 23767681]
Mugwanya K, Baeten JM, Mugo NR, Irungu E, Ngure K, Celum C. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: A randomized, crossover trial. J Infect Dis 2011; 204(12): 1912-7.
[] [PMID: 21998479]
Ganesan A, Fieberg A, Agan BK, et al. Results of a 25-year longitudinal analysis of the serologic incidence of syphilis in a cohort of HIV-infected patients with unrestricted access to care. Sex Transm Dis 2012; 39(6): 440-8.
[] [PMID: 22592829]
Chow EPF, Wilson DP, Zhang L. HIV and syphilis co-infection increasing among men who have sex with men in China: A systematic review and meta-analysis. PLoS One 2011; 6(8): e22768.
[] [PMID: 21857952]
Clure C, Rivard C. Primary Herpes Simplex infection mimicking a cervical malignancy in an immunocompetent individual. Cureus 2018; 10(6): e2753.
[] [PMID: 30094110]
CIPHER. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med 2018; 15(3): e1002514.
Data UNICEF. Statistical Update 2017. Available from: https://data. (Accessed on: 8th March 2020).
Cortés AJ. On how role versatility boosts an STI. J Theor Biol 2018; 440: 66-9.
[] [PMID: 29273545]
National Bureau of Statistics (NBS) and United Nations Children’s. Fund (UNICEF) Multiple Indicator Cluster Survey 2016-17, Survey Findings Report 2017. Available from: https://www.unicef. org/nigeria/NG_publication_mics_201617.pdf (Accessed on: 8th March 2020).

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy